Complementary and alternative therapies in addition to standard oncology protocols are
commonly sought by cancer patients; however, few patients disclose their complementary …

Background PET with computed tomography (PET-CT) is an important imaging modality in
the assessment of patients with cancer. The glucose analogue fluorine-18 2 …

INTRODUCTION: Chronically altered glucose metabolism interferes with 18F-FDG uptake in
malignant tissue and healthy organs and may therefore lower tumor detection in 18F-FDG …

BACKGROUND: Net cellular uptake of 18F-FDG is adversely affected by elevated plasma
glucose levels. The purpose of our study was to investigate the influence of hyperglycemic …

In the last decade, the possibility to map glucose consumption with 2-[18F] fluoro-2-deoxy-D-
glucose (FDG) imaging profoundly modified the daily activity of most nuclear medicine …

The aims of this study were to evaluate the effectiveness of a standardized insulin protocol in
reducing glycemia, review 18F-FDG biodistribution with such a protocol, and assess its …

Patient preparation for FDG PET studies is perhaps more critical and more complex than for
any other commonly performed imaging procedure. We report a patient with normal blood …

For many types of cancer, 18F-FDG PET/CT is commonly used in evaluation and
management, including tumor diagnosis, staging, restaging, treatment monitoring, and …

BACKGROUND: Some patients who undergo 18F-FDG PET/CTfor neoplastic or benign
disease are also affected by diabetes orhyperglycaemia. We propose different preparation …

Purpose The effect of oral hypoglycemic agents on fluorine-18-flurodeoxyglucose (18 F-
FDG) uptake is less understood than the effect of exogenous insulin. In this study, the effect …